CYTH (Cyclo Therapeutics, Inc) Multiplikator Forward P/S

Risks for Cyclo Therapeutics (CYTH) are linked to potential trial failures and competition from gene therapy. Patents on molecules and strict FDA oversight serve as defensive qualities. This chart on GURU.Markets includes a forward P/S indicator, where 23.60 shows the current value of the metric. This price action reflects a stable vote of confidence in management during the adaptation period of clinical programs.

Cyclo Therapeutics, Inc. - Multiplikator Forward P/S CYTH (periode 04.07.2022 - 05.04.2025)

Ringkesan rincian data analitis Cyclo Therapeutics, Inc (CYTH)

- rega pasar lan target rega analis:

Bagan rega Cyclo Therapeutics, Inc.|CYTH - Bagan tingkat prakiraan

- indikator valuasi pasar bisnis:

Kapitalisasi pasar Cyclo Therapeutics, Inc|CYTH - Nilai Dipunlarasaken Utang lan Kas

- statistik nilai buku emiten:

Nilai Buku saben Saham Cyclo Therapeutics|CYTH - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku cyclotherapeutics.com|CYTH - Nilai Agregat Aset

- informasi babagan utang lan solvabilitas:

Utang marang Ekuitas Cyclo Therapeutics|CYTH - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Cyclo Therapeutics|CYTH - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Cyclo Therapeutics, Inc|CYTH - Kewajiban jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Cyclo Therapeutics|Rasio cepet cyclotherapeutics.com

- rincian asil keuangan lan kelipatan valuasi:

CYTH - Penghasilan resik|Bathi sing dikarepake Cyclo Therapeutics|CYTH - Rasio rega marang bathi|Rega marang bathi mangsa ngarep CTD Holdings|CYTH - Rega marang bathi kanthi panyesuaian wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Cyclo Therapeutics, Inc|CYTH - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Cyclo Therapeutics|CYTH - Bathi saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan cyclotherapeutics.com|CYTH - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Cyclo Therapeutics

- data total pendapatan lan volume dodolan:

CYTH - Total pendapatan perusahaan|Prakiraan pendapatan perusahaan Cyclo Therapeutics, Inc.|CYTH - Rasio kapitalisasi pasar marang pendapatan|Multiplikator Forward P/S Cyclo Therapeutics, Inc

Analisis fundamental perusahaan:Cyclo Therapeutics, Inc. CYTH

For the biotech sector, the forward price-to-sales valuation dynamics of Cyclo Therapeutics (CYTH) serve as an indicator of market expectations regarding the monetization of orphan drugs. This metric is calculated as the ratio of current market capitalization to projected annual revenue, allowing for a real-time assessment of the value of scientific competencies and the clinical trial expert staff, bypassing the lengthy intervals between quarterly reports.

Pesaing Cyclo Therapeutics (CYTH)